Lennart Hansson

(Hr. Lennart Hansson Ph.D.)

Currently holds positions in InDex Pharmaceuticals Holding AB, Medivir AB and Calliditas Therapeutics AB

Positions

Position Company Period
Director InDex Pharmaceuticals Holding AB Jan. 1, 2016 -
Director Medivir AB May 3, 2018 -
Non-Executive Director Calliditas Therapeutics AB None -
Lennart Hansson's trades of Medivir AB's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-02-11 2021-02-03
SE Medivir AB (MVIR-B)
B Purchase
10,000
7.00
SEK 7,203 		10,000 7.00 SEK 70,000
2021-02-10 2021-02-03
SE Medivir AB (MVIR-B)
B Purchase
10,000
7.00
SEK 7,203 		10,000 7.00 SEK 70,000
2021-02-04 2021-02-03
SE Medivir AB (MVIR-B)
B Purchase
10,000
7.00
SEK 7,203 		10,000 7.00 SEK 70,000
2021-02-04 2021-02-03
SE Medivir AB (MVIR-B)
B Purchase
10,000
0.00
SEK 0 		10,000 0.00 SEK 0
2019-02-15 2019-02-15
SE Medivir AB (MVIR-B)
B Purchase
10,000
22.26
SEK 22,904 		10,000 22.26 SEK 222,600
// ... existing code ... // ... rest of the file ...